These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1003532)

  • 21. Macrophage accumulation in primary and transplanted tumors growing in C5-deficient B10.D2/oSn mice.
    Evans R
    Int J Cancer; 1980 Aug; 26(2):227-9. PubMed ID: 7203715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered lymphocyte functions in rats bearing syngeneic Moloney sarcoma tumors. II. Suppressor cells.
    Veit BC; Feldman JD
    J Immunol; 1976 Aug; 117(2):655-60. PubMed ID: 950466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Partial characterization of anti-tumor effector macrophages in the peritoneal cavities of concomitantly immune mice and mice injected with macrophage-stimulating agents.
    Hopper KE; Harrison J; Nelson DS
    J Reticuloendothel Soc; 1979 Sep; 26(3):259-71. PubMed ID: 115998
    [No Abstract]   [Full Text] [Related]  

  • 24. Role of a non-committed accessory cell in the in vivo suppression of a syngeneic tumour by immune lymphocytes.
    Simes RJ; Kearney R; Nelson DS
    Immunology; 1975 Aug; 29(2):343-51. PubMed ID: 1158388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumoristatic effects of nonimmune BALB/c peritoneal macrophages on syngeneic lymphoma cells in vitro.
    Li J; Mansfield M; Wallace JH
    Oncology; 1977; 34(6):245-50. PubMed ID: 593652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macrophage inflammatory responses in rats and mice with autochthonous and transplanted tumors induced by 3-methylcholanthrene.
    Normann SJ; Schardt MC; Sorkin E
    J Natl Cancer Inst; 1984 Jan; 72(1):175-84. PubMed ID: 6229667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrophage activities in sarcoma 180-bearing mice and EL4-bearing mice.
    Kurashige S; Mitsuhashi S
    Gan; 1982 Feb; 73(1):85-90. PubMed ID: 6749590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Macrophage function in tumor-bearing mice: dissociation of phagocytic and chemotactic responsiveness.
    Meltzer MS; Stevenson MM
    Cell Immunol; 1978 Jan; 35(1):99-111. PubMed ID: 620431
    [No Abstract]   [Full Text] [Related]  

  • 29. Suppressive effect of 3-methylcholanthrene on phagocytic activity of mouse peritoneal macrophages for Torulopsis glabrata.
    Tewari RP; Balint JP; Brown KA
    J Natl Cancer Inst; 1979 Apr; 62(4):983-8. PubMed ID: 285299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The effect of macrophages on the natural killer activity of the splenocytes of C3HA mice in the early stages of 20-methylcholanthrene-induced carcinogenesis].
    Pogodina ON; Malygin AM; Goriunova LB; Fel' VIa
    Tsitologiia; 1989 Nov; 31(11):1385-90. PubMed ID: 2626785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrophage function in tumor-bearing mice: tumoricidal and chemotactic responses of macrophages activated by infection with Mycobacterium bovis, strain BCG.
    Meltzer MS; Stevenson MM
    J Immunol; 1977 Jun; 118(6):2176-81. PubMed ID: 325142
    [No Abstract]   [Full Text] [Related]  

  • 32. [Antitumoral effect of peritoneal macrophages activated by a water-soluble adjuvant of mycobacterial origin].
    Juy D; Bona C; Chedid L
    C R Acad Hebd Seances Acad Sci D; 1974 May; 278(22):2859-62. PubMed ID: 4212547
    [No Abstract]   [Full Text] [Related]  

  • 33. Time-lapse changes in the concomitant immunity of lymphocytes from different sites of mice isografted with methylcholanthrene-induced tumor.
    Orita K; Ohnishi N; Matuso Y; Konaga E; Kokumai Y
    Acta Med Okayama; 1975 Apr; 29(2):85-91. PubMed ID: 126005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of antibody in the inhibition of the growth of Meth.A tumour in syngeneic experiments in vivo and in vitro.
    Farram E; Festenstein H; de Giorgi L
    Clin Exp Immunol; 1978 Sep; 33(3):377-85. PubMed ID: 737892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-tumor immunity in B lymphocyte-deprived mice. I. Immunity to a chemically induced tumor.
    Brodt P; Gordon J
    J Immunol; 1978 Jul; 121(1):359-62. PubMed ID: 307580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mouse mononuclear cell chemotaxis. I. Differential response of monocytes and macrophages.
    Boumsell L; Meltzer MS
    J Immunol; 1975 Dec; 115(6):1746-8. PubMed ID: 1184970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antitumor activity of macrophages grown in tumorous ascitic fluid.
    Yamazaki M; Ikenami M; Yui S; Esumi-Kurisu M; Mizuno D
    Gan; 1983 Feb; 74(1):155-61. PubMed ID: 6840434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An inhibitor of macrophage chemotaxis produced by neoplasms.
    Snyderman R; Pike MC
    Science; 1976 Apr; 192(4237):370-2. PubMed ID: 946556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macrophages and resistance of tumors 6. The effects of supernatants from cultures of normal and tumor cells on phagocytosis.
    Nelson M; Nelson DS
    J Reticuloendothel Soc; 1982 May; 31(5):433-50. PubMed ID: 7120229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of the splenic cells of tumor-bearing mice on the allograft immune response].
    Spasokukotskiĭ AL
    Vopr Onkol; 1985; 31(7):87-91. PubMed ID: 4024565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.